T
he variable (V) regions of syngeneic antibodies (Abs), called idiotypes (Ids), can provoke immune responses (1, 2) that are T helper cell (Th)-dependent (3) (4) (5) (6) (7) . When administered in small amounts as free Abs without added adjuvant, a minor but significant fraction (Ϸ5%) of IgM anti-2,4,6-trinitrophenyl (TNP) monoclonal (m)Abs of the primary repertoire elicited anti-Id Ab responses in BALB͞c mice (8) , which provided an opportunity to study the influence of the heavy-chain constant region (C H ) isotypes on the immunogenicity of Ids. Since free anti-TNP mAb-turned immunogens contain built-in C H regions, the isotype effect can be studied without the confounding variables of immune complex formation such as Ab affinities, the quality and quantity of antigen (Ag)-Ab complexes, rapid clearance or enhanced presentation of the Ag, and masking of antigenic sites.
Apart from a short report showing that injection of a plain IgG myeloma protein into mice led to tolerance to the Id of this IgG (9) , and a study from this laboratory indicating that an Id that is immunogenic when borne by IgM, becomes tolerogenic when borne by IgG1, IgG2a, and IgG2b (10), limited information is available on the significance of Ig isotypes for the immunogenicity of Ids. We here study immune responses to switch variants of two mAbs, called Id 3 and Id A.01 , selected because they induce potent immunity when borne by adjuvant-free IgM (8, 10, 11) .
Materials and Methods
Mice. BALB͞c female mice were purchased from Charles River Breeding Laboratories or Harlan Olac (Bichester, U.K.). Fc␥RII Ϫ/Ϫ and FcR␥ Ϫ/Ϫ mice on a BALB͞c background were purchased from Taconic Farms. The mice were 7-12 weeks old at the start of the experiments. The animals were maintained specific pathogen-free as described (8) .
Mono-and Polyclonal Ab. Hybridoma EM95-producing rat IgG anti-mouse IgE was a gift of Z. Eshar, The Weizmann Institute of Science, Israel. The EM95 mAb was affinity purified on Sepharose-coupled MAR 18.5 (mouse anti-rat kappa, ATCC TIB-216) and used together with biotin-labeled sheep antimouse IgE (The Binding Site, Birmingham, U.K.) to detect IgE-producing switch variants of Id 3 . Affinity-purified unconjugated and biotin-conjugated polyclonal Abs specific for mouse IgA, IgG, and IgG subclasses were purchased from Jackson ImmunoResearch, or Southern Biotechnology Associates, or Zymed. Syngeneic IgG1 anti-Id 3 mAb, called TREC1.1 (8) , and anti-Id A.01 mAb designated ANUL1, were produced by hybridomas (our local collection) derived from BALB͞c mice immunized with the homologous Id borne by IgM.
Isolation of Rare Spontaneous Class Switch Variants. Rare subclones in which the V H exon spontaneously rearranged to a new C H element were identified by sandwich ELISA by using isotypeand IgG subclass-specific Abs as described (12 was converted to 8S monomers by reduction with 0.01 M DTT for 1 h at 37°C and alkylation with 0.015 M iodoacetamide, followed by sizeexclusion FPLC on Superose 6 HR. Digestion of IgG1-Id A.01 with pepsin (25 g/ml) was performed in 0.1 M citrate, pH 3.5, at 37°C for 5 h. The digest was subjected to FPLC on Superose 6 HR (Amersham Pharmacia), and fractions corresponding to M r Ϸ 100 kDa were collected. The cleavage of IgG was complete as indicated by SDS͞PAGE with 12% acrylamide and Coomassie blue staining.
Immunizations. All immunogens were stored sterile at 4°C and injected in sterile pyrogen-free saline without added adjuvant. All priming injections were given s.c. at the base of the tail and three to four sites on the back because by this route Ags are delivered to regional draining lymph nodes. Three weeks later biweekly i.p. boosters were begun. The mice were bled from the femoral vein before and 3 weeks after priming and 2 weeks after each booster.
ELISA. Sera from animals immunized with the various switch variants were assessed for IgG anti-Id Ab activity by ELISA as described (8) , by using the homologous Id born by IgM mAb as coat Ag, and alkaline phosphatase-conjugated rabbit anti-mouse IgG (Zymed) as second Ab.
Results
The Influence of Various CH Isotypes on the Immunogenicity of Id. We examined the immunogenicity of Id 3 borne by IgG3, IgA, and IgE. The results are shown in Fig. 1 . None of six BALB͞c mice responded to immunization with IgG3-Id 3 ( Fig. 1 A) which, therefore, is nonimmunogenic in common with Id 3 borne by IgG1, IgG2a, and IgG2b (10). Immunization with IgE-Id3 (100 g ϩ 50 g ϫ 3) elicited large amounts of IgG anti-Id 3 Abs (90-300 g/ml) in 4 of 6 animals, and weaker but clearly significant responses (2-10 g/ml) developed in 2 of 3 mice immunized with a 25-fold lower dose (Fig. 1B) , and in 1 of 3 animals given 25 g ϩ 12 g ϫ 3 (data not shown). With respect to the natural (i.e., not chemically treated) mIgA-Id 3 , 16 of 17 animals immunized with doses ranging from 10 g ϩ 5 g ϫ 3 to 90 g ϩ 45 g ϫ 2 produced Ͼ1 g/ml of anti-Id 3 IgG (Fig.  1C , and data not shown). In striking contrast, none of 14 animals injected with the same dose range of pIgA-Id 3 responded (Fig.  1D , and data not shown).
To examine whether the nonimmunogenicity of Id born by IgG is unique to Id 3 or has broader application, we turned to the potently immunogenic Id of a nonmutated IgM2 anti-TNP mAb called Id A.01 (8) . All animals immunized with IgM-Id Abs had reached a mean of 105 g/ml (Fig. 1H) , indicating that by removing the Fc␥ piece from IgG1, Id A.01 regained immunogenicity. All of the described antisera contained anti-Id IgG1, but not IgG2a, exclusively specific for the Id used for immunization and they did not contain anti-BSA IgG (data not shown), confirming previous results (8) .
Ids Borne by IgG3 and IgG1 Induce Long-Lasting Unresponsiveness. To ascertain whether IgG3 induces unresponsiveness to Id, mice were injected s.c. with IgG3-Id . As shown in Fig. 2B , the mean humoral response to Id A.01 of mice that had not been preinjected with IgG1, was Ϸ10,000 times higher than that of the preinjected animals (e.g., 1,800 g/ml vs. 0.17 g/ml). Another group of animals that received a series of four biweekly IgG1-Id (Fig. 3) . In a parallel experiment, the anti-BSA responses of animals immunized repeatedly with adjuvant-free BSA mixed with IgG1-Id A.01 did not differ appreciably from those of mice given BSA alone (data not shown). In addition, mice preinjected with IgG2a-Id 3 and that were unresponsive to challenge with IgM-Id 3 , responded to IgM-Id A.01 (data not shown). Thus, the unresponsiveness induced by Id A.01 of IgG1 is specific and cannot be prevented by coinjection of Id A.01 borne by IgM.
Unresponsiveness to Id Can Develop When Id Borne by IgG Is Injected
After Priming with IgM. These findings, and the fact that production of IgG Abs is delayed relative to IgM during primary immune responses, led us to speculate that when Ids switch isotype from IgM to IgG they suppress spontaneous in vivo immune responses against shared Ids borne by their IgM progenitors. To test this hypothesis directly, we examined whether unresponsiveness to Id can develop when the first injection of IgG is given after priming with IgM. The experiment is described and the results are shown in Fig. 4 . Three of five animals in the control group produced anti-Id A.01 IgG. By contrast, none of the 12 mice that received additional IgG1 3 or 7 days after priming with IgM mounted a detectable Ab response to Id A.01 . Moreover, of the 12 mice that received the first injection of IgG1-Id A.01 11 or 21 days after IgM-Id A.01 , only two responded, i.e., significantly fewer than the controls (P Ͻ 0.02). Thus, Ids that have switched to IgG powerfully suppress humoral responses to immunogenic Id of their IgM forerunners encountered up to 21 days earlier.
Ids of IgG Fail to Elicit Anti-Id Abs in Mice Deficient in Fc␥RIIB or Fc␥RI
؉ Fc␥RIII (Fc␥RIIB ؊/؊ or FcR␥ ؊/؊ ). Mice deficient in Fc␥RIIB (14) responded to IgM-Id (Fig. 5C) . We conclude that the failure to develop immunity to IgG-borne Ids depends neither on Fc␥RIIB alone nor on Fc␥RI ϩ Fc␥RIII. Mice lacking all three Fc␥R on a BALB͞c background were not available.
Responsiveness to Id 3 Borne by IgE and IgA Is Intact in Mice Lacking
Fc␥RI ؉ Fc␥RIII ؉ FcRI (FcR␥ ؊/؊ ). Because FcR␥ Ϫ/Ϫ mice lack expression of the high-affinity FcRI, we immunized five mice with Id 3 borne by IgE. Three mice produced large amounts of IgG anti-Id 3 Ab (Fig. 6A) . We also considered the possibility that mouse IgA-receptors (Fc␣R) might exist which, like the human Fc␣R CD89, use the common activation subunit, the ␥-chain. We therefore immunized FcR␥ Ϫ/Ϫ mice with Id 3 borne by pIgA and by mIgA derived from pIgA by reduction͞alkylation. Confirming the results with natural mIgA and pIgA in wild-type mice ( Fig. 1 C and D) , FcR␥ Ϫ/Ϫ animals mounted strong responses to mIgA-Id 3 and were completely nonresponsive to Id 3 of pIgA (Fig. 6A) . The pIgA-Id 3 -injected animals also failed to respond to a subsequent immunization-challenge with secretory IgM-Id 3 (Fig. 6B) . The results suggest that (i) FcRI is not required for responses to Id 3 of IgE, (ii) if Fc␣ receptors that depend on the ␥-chain exist in the mouse, they are not required for the striking differential response to Id 3 borne by mIgA versus pIgA, and (iii) pIgA can be tolerogenic.
Discussion
The present and previous (10) results indicate that immunogenic Ids borne by adjuvant-free IgM anti-TNP mAbs acquire tolerogenicity by switching to IgG1, 2a, 2b, 3, or pIgA, regain immunogenicity when the Fc piece of IgG1 is removed, and maintain immunogenicity by switching to IgE and natural IgA monomers. Because Th-dependent Ags usually induce naive B cells of the systemic and mucosal immune systems to undergo class switching to IgG and pIgA, respectively, the Ig isotype-based negative regulation of Id immunity may operate in both compartments, which may be advantageous. However, because the therapeutic IgG mAb anti-CD52 (Campath) is immunogenic (15), Ids of IgG Abs with autoreactivity need further study.
The mechanism underlying the differential immunogenicity of Id borne by the various isotypes remains unclear. Masking of serum anti-Id Abs by soluble IgG Id is very unlikely given that tolerance was still intact 90 days after the last injection of IgG. Because immunogenic forms such as IgM, IgE, and F(abЈ) 2 ␥, have shorter half-lives than tolerogenic IgG, brief presence of Id might be immunogenic, whereas continued exposure could be tolerogenic. However, the fact that nonimmunogenic pIgA is cleared more rapidly than mIgA by the poly(Ig) receptor of mouse hepatocytes (16, 17) , is not in accord with this hypothesis. , and 8S IgM subunits of Id A.01 were immunogenic, and (ii) pIgA, which should be a good cross-linker, was nonimmunogenic. One possible scenario is based on the ability of CD19 to amplify BCR-mediated signaling and augment humoral immune responses when it is cross-linked to BCR of naive B cells (18) . Thus, when free IgM binds to surface Ig of anti-Id B cells, it might coligate BCR and the CR2͞CD19 coreceptor either by means of attached split products of C4 and C3, or independently of complement (19) . However, CD19-dependent mechanisms cannot be required for Id immunogenicity because Id 3 borne by mIgA and Id A.01 of F(abЈ) 2 ␥, which do not bind CD19 (19) and are weak complement activators, and IgE that does not activate complement at all (20) , were also immunogenic. We cannot rule out that IgE-Id regained immunogenicity when IgG1 was converted to F(abЈ) 2 indicated that engagement of Fc␥ receptors is required for the negative response to Id. Two principal ways exist by which Fc␥RI, IIB, and III can inhibit anti-Id responses. The first is cocrosslinking of BCR with Fc␥RIIB on B cells, leading to inhibition of B cell activation (22, 23) and B cell antigen presentation to T cells (24, 25) . However, mice lacking Fc␥RIIB were also nonresponders to Id borne by all IgG subclasses, including IgG3, demonstrating that Fc␥RIIB alone is not responsible. Furthermore, it is unlikely that significant coligation of Fc␥RIIB and anti-Id BCR remained 80-90 days after the last injection of IgG, yet tolerance to Id of IgM was still intact. The second way is that anti-Id B cells that had bound Id of IgG Ab were killed by Ab-dependent cell-mediated cytotoxicity (ADCC), as exemplified by the efficient in vivo elimination of aggressive B cell tumors mediated by IgG Abs (26, 27) . ADCC could account for the negative response to Id of mice given IgG1 Id A.01 up to 80-90 days before or 3-21 days after challenge with IgM. In this regard, we found that FcR␥ Ϫ/Ϫ mice that are deficient in FcRI and III still failed to respond to both IgG2a-and IgG3-switch variants of Id 3 . Because Fc␥RIII is the only known Fc␥R of NK cells (28), a principal cell type involved in ADCC, the result suggested that NK cell-mediated cytotoxicity was not substantially involved. ADCC mediated by Fc␥RIIB expressed on monocytes͞macrophages of FcR␥ Ϫ/Ϫ mice also seems unlikely, because Fc␥RIIB inhibits calcium mobilization and the calcium-dependent ADCC function (27, 29) . Our finding that IgG3-Id 3 was nonimmunogenic and induced tolerance to immunization challenge with IgM-Id 3 opens the possibility that alternative Fc␥ receptors, as yet uncharacterized, were involved (30, 31) . On this note, a family of human Fc receptor homologs with preferential B cell expression has recently been described (32) .
The present observations on IgA-Id 3 , together with a previous study of adjuvant-free myeloma protein IgA (315) (7) , indicate that, in the absence of added adjuvant, Ids are dramatically more immunogenic when borne by mIgA (and IgM) than by pIgA. This finding is surprising in view of the similarity in higher order structure and transport of pIgA and IgM (20) , and it is not due to chemical treatment (reduction/alkylation), because natural mIgA Id 3 too was immunogenic (Fig. 1C) . In the human, the transferrin receptor has recently been shown to bind mIgA1 better than pIgA1 (33), but it is not known whether the murine transferrin receptor binds IgA. Possible involvement of the receptor for both IgM and IgA (Fc␣͞R) (34, 35) cannot explain the differential immunogenicity of Id borne by pIgA and IgM. Finally, effector cells bearing an alternative, as yet unknown, IgA Fc receptor might attack anti-Id B cells much more efficiently by way of bound pIgA than mIgA. When mixed with complete Freund's adjuvant, however, polymeric forms of an IgA myeloma protein (S117) also elicited anti-Id Ab responses (36) , perhaps because complete Freund's adjuvant lowers the threshold for Th cell activation and decreases Th cell apoptosis (37) .
Because humoral responses to Ids of particular adjuvant-free mAbs depend on Th cells (3-7), probably Th2 (8), our study leaves open the possibility that APCs such as B cells (38, 39) or immature dendritic cells (DCs) (40) presented Ids borne by IgG and pIgA in a nonimmunogenic or tolerogenic form to Th cells. In that case, B cells would receive signal 1 from their anti-Id BCR in the absence of T cell help (signal 2). According to the two-signal model of acquired immunity (41; reviewed in ref. 42) , this reception of signal 1 should lead to B cell tolerance. The observation that mice injected with hapten-conjugated polyclonal mouse IgG became tolerant to the hapten (43, 44) is compatible with this scenario, although ADCC was not ruled out. However, this model fails to explain why supposed absence of signal 2 was limited to IgG and pIgA. Perhaps pepsin treatment of IgG and subtle denaturation of IgM, mIgA, and IgE during purification led to ''altered self'' with acquisition of immunogenicity. Although a significant role for ''altered self'' cannot be excluded, we think it is unlikely because (i) the Ids of the present and previous (8) studies were purified under gentle conditions, (ii) only Ϸ5% of 73 purified IgM anti-TNP mAbs were immunogenic (8) , (iii) we are not aware that natural mIgA has been shown to be more susceptible to denaturation than pIgA, and (iv) denatured Igs are also produced during in vivo catabolism. The two-signal model also does not easily explain why the mice were nonresponders to Id A.01 injected as a mixture of IgG and IgM species, because in this situation Id A.01 borne by IgM should activate Id A.01 -specific Th that provided signal 2 for the B cells. On this note, an emerging notion is that proteins captured and processed by DCs in the steady state, i.e., immature DCs, are tolerogenic because they delete T cells or induce suppressor T cells (40) . Applied to our data this hypothesis, in common with the two-signal model, does not easily account for the differential effect of C H isotypes on Id immunogenicity. Furthermore, on the basis of previous data, we have argued that Id A.01 IgM can elicit Th2 immunity without an adjuvant (8) , and others have observed that MyD88-deficient mice with defective Toll function can make ovalbumin-specific IgG1 after immunization with ovalbumin in complete Freund's adjuvant (45) . Thus, immature or resting DCs may indeed support responses of Th type 2 cells. If that is so, it is of obvious importance for physiological Id immunity.
It is relevant to consider our results in light of Jerne's Id network theory of the immune system (46) . We found a positive response when anti-Id 3 paratopes (i.e., antigen-binding sites) on BCRs recognized free IgE Id 3 . Others have reported that when a public Id on BCRs was recognized by the paratopes of free antipublic Id IgE, the Id was suppressed (47) . These opposite results agree with Jerne's tentative proposal that stimulation occurs when paratopes on receptor molecules recognize Ids on free Abs, and repression ensues in the reverse situation when Ids of receptor molecules are recognized by paratopes of free Abs (46) . However, chances are that the IgE antipublic Id mAb of Muller and Rajewsky was nonimmunogenic. If so, it differed radically from IgE-Id 3 , which might account for its repression of Id. We propose that a positive or negative outcome of Id-based interactions between BCRs and free Abs is determined by a combination of the isotype of the free mAbs and the immunogenicity of their Ids. Accordingly, free Abs that have (i) immunogenic Ids, (ii) a permissive isotype (IgM, mIgA, and IgE), and (iii) paratopes that recognize a given Id will augment expression of that Id. On the basis of our previous studies (4-6, 8, 48) , we hypothesize that in this situation the immunogenic anti-Id set augments expression of their target Id by inducing collaboration between target Id-bearing B cells and Th specific for V-region peptides derived from the anti-Id set. On the other hand, treatment of neonatal or adult mice with free anti-Id Abs bearing a dominant nonpermissive isotype (IgG, pIgA) should lead to long-lasting loss of expression of that Id, in agreement with published data for IgG (reviewed in ref. 49) .
Although the role of Ids as endogenous immunogens still remains to be established, they are significant for therapeutic application of Abs. The present work suggests that class switching to IgG and pIgA may serve to dampen Id immunity, which may be advantageous.
